Active — Not RecruitingNot Applicable

Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text Messaging

United States70 participantsStarted 2016-05

Plain-language summary

The investigators will explore barriers to improving self-efficacy, or the ability to feel in control of their disease, and medication adherence with text messaging through surveys and interviews with adolescents and adults with SCD cared for at the Vanderbilt Meharry Center of Excellence (VMCE) in Sickle Cell Disease (SCD). The investigators will identify preferences to improve and sustain adherence to daily medication through selection of investigator-proposed or patient-generated text messaging strategies. Finally, the investigators will fill in the literature gaps by describing barriers to self-efficacy and medication adherence among adults with SCD as well as adolescents with SCD who are transitioning to adult care.

Who can participate

Age range12 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Receiving care at the VUMC/Matthew Walker clinic
✓. Diagnosed with SCD, asthma, or both
✓. Currently taking daily medications for SCD, such as hydroxyurea, asthma, or both
✓. Having access to a mobile telephone and/or computer
✓. Age 12-70 years

What they're measuring

Number of patients with barriers to medication adherence

Timeframe: 1 year

Trial details

NCT IDNCT02785848

SponsorVanderbilt University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-05

View on ClinicalTrials.gov More Sickle Cell Disease trials